Price Cut Ahead Novo Nordisk is cutting prices for its weight-loss and diabetes drugs, Wegovy and Ozempic. Starting in 2027, you’ll pay $675 per month for these meds. It’s a move that won’t shock many, given the public outcry over

Continue ReadingNovo Nordisk Slashes Prices: $675 for Weight-Loss Meds

Novo Nordisk’s Bad Day Novo Nordisk’s stock price took a nosedive, sinking 15% on Monday. Why? Its next-gen weight loss drug failed to impress in trials, not coming close to matching Eli Lilly’s results. It’s a blow to the company,

Continue ReadingNovo Nordisk Stock Plummets 15% After Weight Loss Drug Flop

Novo Nordisk’s TV Ad Gets Slapped by FDA The FDA just told Novo Nordisk to stop running its TV ad for an obesity pill, saying it’s full of ‘false or misleading’ claims. They’re giving the company an ultimatum: fix the

Continue ReadingFDA Calls Out Novo Nordisk’s Sleazy Obesity Pill Ads